Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 88701-88750 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05303636
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
PHASE4
Recruiting
1,710 participants
Started: Mar 28, 2022 · Completed: Mar 31, 2027
2 conditions
2 sponsors
20 locations
NCT05565781
Smartwatch and External Holter Monitoring to Detect Atrial Fibrillation in Patients With Cryptogenic Stroke
NA
Recruiting
100 participants
Started: Mar 28, 2022 · Completed: Sep 1, 2026
2 conditions
1 sponsor
1 location
NCT05262530
Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid Tumors
PHASE1/PHASE2
Active, not recruiting
73 participants
Started: Mar 28, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
18 locations
NCT05319561
Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team
NA
Active, not recruiting
8 participants
Started: Mar 28, 2022 · Completed: Mar 31, 2026
3 conditions
1 sponsor
2 locations
NCT06344507
Iconographic Registry of Pancreatobiliary Endoscopy Procedures
N/A
Recruiting
12,000 participants
Started: Mar 28, 2022 · Completed: Dec 31, 2027
4 conditions
1 sponsor
1 location
NCT05143229
Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer
PHASE1
Active, not recruiting
18 participants
Started: Mar 28, 2022 · Completed: Dec 31, 2025
1 condition
3 sponsors
7 locations
NCT06879535
Long-term Symptomatic Follow-up of Patients with Long COVID Syndrome
N/A
Active, not recruiting
80 participants
Started: Mar 28, 2022 · Completed: Mar 28, 2025
1 condition
1 sponsor
1 location
NCT05317793
Ambulatory Electrodermal Activity Measurements as Part of Identification and Prevention of Job Burnout
N/A
Active, not recruiting
123 participants
Started: Mar 28, 2022 · Completed: Dec 31, 2026
4 conditions
2 sponsors
3 locations
NCT04895436
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
PHASE2
Recruiting
75 participants
Started: Mar 28, 2022 · Completed: Jan 31, 2029
1 condition
2 sponsors
56 locations
NCT04965454
Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma
PHASE2
Recruiting
80 participants
Started: Mar 28, 2022 · Completed: Jun 30, 2028
1 condition
2 sponsors
1 location
NCT05298904
Pro-active Genetic Testing in Kidney Transplant Patients
N/A
Active, not recruiting
177 participants
Started: Mar 28, 2022 · Completed: Mar 1, 2038
1 condition
1 sponsor
1 location
NCT05301842
Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCC
PHASE3
Active, not recruiting
760 participants
Started: Mar 28, 2022 · Completed: Feb 26, 2027
1 condition
1 sponsor
171 locations
NCT05279300
A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas
PHASE1
Recruiting
480 participants
Started: Mar 28, 2022 · Completed: Dec 31, 2027
2 conditions
1 sponsor
38 locations
NCT05401318
Tailoring Treatment in Colorectal Cancer
N/A
Recruiting
40 participants
Started: Mar 28, 2022 · Completed: Jan 1, 2027
1 condition
3 sponsors
1 location
NCT05095376
Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
PHASE3
Recruiting
306 participants
Started: Mar 28, 2022 · Completed: Aug 8, 2026
2 conditions
2 sponsors
403 locations
NCT04966663
Using ctDNA to Determine Therapies for Lung Cancer
PHASE2
Recruiting
66 participants
Started: Mar 28, 2022 · Completed: Dec 1, 2026
3 conditions
2 sponsors
1 location
NCT05155332
A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)
PHASE1
Recruiting
190 participants
Started: Mar 28, 2022 · Completed: Oct 31, 2028
1 condition
1 sponsor
40 locations
NCT05052736
Non Invasive Neurostimulation Technology for the Treatment of Type I Complex Regional Pain Syndrome (CRPS I)
NA
Recruiting
42 participants
Started: Mar 28, 2022 · Completed: Dec 27, 2026
1 condition
1 sponsor
1 location
NCT05315570
Big Data for Quality of Life in Head and Neck Cancer
NA
Recruiting
420 participants
Started: Mar 28, 2022 · Completed: Jun 1, 2025
3 conditions
16 sponsors
3 locations
NCT05099393
Effect of Non-nutritive Sweeteners on Vascular Function in Humans
NA
Recruiting
40 participants
Started: Mar 28, 2022 · Completed: Nov 30, 2024
1 condition
1 sponsor
1 location
NCT06910566
Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy
N/A
Recruiting
100 participants
Started: Mar 28, 2022 · Completed: Dec 31, 2025
5 conditions
1 sponsor
1 location
NCT05183126
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
PHASE4
Recruiting
22 participants
Started: Mar 28, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT05337501
Prognostic Factors for Complex Regional Pain Syndrome
NA
Active, not recruiting
113 participants
Started: Mar 28, 2022 · Completed: Dec 30, 2024
1 condition
2 sponsors
1 location
NCT05267184
Swedish Trial on Embolization of Middle Meningeal Artery Versus Surgical Evacuation in Chronic Subdural Hematoma
NA
Recruiting
288 participants
Started: Mar 28, 2022 · Completed: Mar 31, 2027
1 condition
5 sponsors
4 locations
NCT05208411
Prodromal ImPACT Intervention for Children at Elevated Likelihood of ASD
NA
Recruiting
80 participants
Started: Mar 28, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06075446
Calling All Dads! Evaluation of APAs ACT Program: Engaging Fathers to Prevent Adverse Childhood Experiences
N/A
Active, not recruiting
500 participants
Started: Mar 28, 2022 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT06001632
Changes in Muscle Strength, Inflammatory Markers, and Body Composition in Response to Alternate Day Fasting Combined With Krill Oil Supplementation in Adults With Overweight and Obesity
NA
Recruiting
50 participants
Started: Mar 28, 2022 · Completed: Nov 20, 2024
1 condition
1 sponsor
1 location
NCT05083403
HPI (Hypotension Prediction Index) Care Trial
NA
Active, not recruiting
350 participants
Started: Mar 28, 2022 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT05290194
Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma
PHASE2
Recruiting
28 participants
Started: Mar 28, 2022 · Completed: Jan 1, 2027
4 conditions
1 sponsor
1 location
NCT05305131
Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer
PHASE2
Recruiting
50 participants
Started: Mar 28, 2022 · Completed: Dec 28, 2026
1 condition
1 sponsor
1 location
NCT05352074
STOPS Trial: Total vs Subtotal Colectomy for Slow Transit Constipation
NA
Recruiting
252 participants
Started: Mar 27, 2022 · Completed: Dec 31, 2028
2 conditions
1 sponsor
16 locations
NCT05311566
PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer
PHASE2
Recruiting
92 participants
Started: Mar 27, 2022 · Completed: Mar 27, 2026
9 conditions
1 sponsor
1 location
NCT04961528
ACid Tranexamic or Terlipressin for Initial Emergency Treatment of Mild to seVere hEmoptysis: a Randomized Trial.
PHASE3
Recruiting
315 participants
Started: Mar 27, 2022 · Completed: Jan 31, 2026
1 condition
2 sponsors
1 location
NCT04825522
The Effect of Intrawound Vancomycin Powder in Spine Surgery
PHASE4
Recruiting
1,643 participants
Started: Mar 27, 2022 · Completed: Dec 1, 2028
1 condition
2 sponsors
2 locations
NCT05849376
Emergent Multi-Class Imitation Training
NA
Recruiting
25 participants
Started: Mar 27, 2022 · Completed: Aug 31, 2027
1 condition
1 sponsor
1 location
NCT04730024
Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj
N/A
Not yet recruiting
102 participants
Started: Mar 27, 2022 · Completed: Jun 30, 2030
1 condition
1 sponsor
1 location
NCT04056533
Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy
PHASE2
Recruiting
15 participants
Started: Mar 26, 2022 · Completed: Dec 1, 2026
1 condition
1 sponsor
1 location
NCT03897374
Strategic Targeting for Optimal Prevention of Cancer
N/A
Recruiting
120,000 participants
Started: Mar 26, 2022 · Completed: Dec 1, 2027
1 condition
2 sponsors
1 location
NCT05330351
Gastric Ultrasound in Pediatric Trauma Patients
N/A
Recruiting
40 participants
Started: Mar 26, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05168384
Safety and Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Multiple Sclerosis
PHASE1/PHASE2
Active, not recruiting
15 participants
Started: Mar 26, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT04867590
A Study Comparing the Effectiveness of EndoRotor Versus Radiofrequency in Treating Barrett's Esophagus
NA
Recruiting
140 participants
Started: Mar 25, 2022 · Completed: May 31, 2027
2 conditions
1 sponsor
12 locations
NCT04985903
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
NA
Recruiting
840 participants
Started: Mar 25, 2022 · Completed: Feb 27, 2026
3 conditions
2 sponsors
1 location
NCT05155098
2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis
N/A
Active, not recruiting
127 participants
Started: Mar 25, 2022 · Completed: Aug 29, 2025
4 conditions
1 sponsor
10 locations
NCT04106115
DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr
PHASE1/PHASE2
Recruiting
64 participants
Started: Mar 25, 2022 · Completed: May 31, 2029
1 condition
3 sponsors
5 locations
NCT05165095
Clinical Assessment of Essential Remote Monitoring Functions in Pacemakers
N/A
Recruiting
206 participants
Started: Mar 25, 2022 · Completed: Jul 31, 2027
2 conditions
1 sponsor
19 locations
NCT05035459
B-lines-guided Heart Failure Management in Heart Failure Patients
N/A
Active, not recruiting
320 participants
Started: Mar 25, 2022 · Completed: Aug 25, 2024
2 conditions
1 sponsor
1 location
NCT05280626
First-line Treatment of P53 Mutation With PD-L1 Expression in DLBCL With Anti-PD-1 Mab and R-CHOP
PHASE2
Not yet recruiting
100 participants
Started: Mar 25, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
0 locations
NCT05152524
Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever
NA
Recruiting
168 participants
Started: Mar 25, 2022 · Completed: Jan 31, 2026
2 conditions
1 sponsor
25 locations
NCT05317416
Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant
PHASE3
Recruiting
760 participants
Started: Mar 25, 2022 · Completed: Oct 31, 2029
1 condition
1 sponsor
219 locations
NCT05348577
Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)
PHASE3
Active, not recruiting
1,035 participants
Started: Mar 25, 2022 · Completed: Mar 4, 2026
1 condition
1 sponsor
217 locations
Previous
1
More pages
1772
1773
1774
1775
1776
1777
1778
More pages
2369
Next